ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Adrian Rawcliffe, Adaptimmune"
Episode Synopsis
This episode features Adrian (Ad) Rawcliffe, CEO, Adaptimmune, recipient of the Life Sciences PA 2024 Patient Impact Award.Ad shares the story behind TECELRA - the first FDA approved engineered cell therapy for a solid tumor. Learn about the journey leading up to this groundbreaking approval, the challenges of bringing a cell therapy to market and the next steps for Adaptimmune in the landscape of tumor treatments.
More episodes of the podcast Being a Life Sciences Leader
Bill Sibold, Madrigal Pharmaceuticals
29/04/2025
Devlin Robinson, PA State Senate
25/03/2025
Ben Doranz, PhD, MBA, Integral Molecular
11/03/2025
Fred Vogt, Iovance Biotherapeutics
26/02/2025
Rob Albert, B. Braun
20/02/2025
Adele Oliva, 1315 Capital
29/01/2025
Jeff O'Donnell, Runway Healthcare
22/01/2025
In God we trust